VERGALLO, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 3.139
AS - Asia 1.414
EU - Europa 1.227
SA - Sud America 242
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 81
OC - Oceania 9
Totale 6.225
Nazione #
US - Stati Uniti d'America 3.058
SG - Singapore 451
CN - Cina 386
IT - Italia 347
SE - Svezia 216
HK - Hong Kong 205
BR - Brasile 190
DE - Germania 178
VN - Vietnam 157
BG - Bulgaria 80
FR - Francia 76
GB - Regno Unito 75
FI - Finlandia 48
CA - Canada 40
CI - Costa d'Avorio 39
AT - Austria 38
RU - Federazione Russa 38
IN - India 34
TR - Turchia 28
NL - Olanda 24
BD - Bangladesh 23
JP - Giappone 22
PL - Polonia 20
AR - Argentina 18
MX - Messico 17
CZ - Repubblica Ceca 16
ES - Italia 16
KR - Corea 15
VE - Venezuela 13
GR - Grecia 12
PK - Pakistan 12
ID - Indonesia 11
SN - Senegal 11
TW - Taiwan 11
UA - Ucraina 11
IQ - Iraq 10
AU - Australia 9
ZA - Sudafrica 9
SA - Arabia Saudita 8
BE - Belgio 7
EC - Ecuador 6
PE - Perù 6
EG - Egitto 5
HN - Honduras 5
IE - Irlanda 5
IL - Israele 5
AZ - Azerbaigian 4
CH - Svizzera 4
CR - Costa Rica 4
DZ - Algeria 4
IR - Iran 4
MA - Marocco 4
NG - Nigeria 4
PH - Filippine 4
BB - Barbados 3
CO - Colombia 3
LB - Libano 3
LT - Lituania 3
MY - Malesia 3
PA - Panama 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
JM - Giamaica 2
JO - Giordania 2
NO - Norvegia 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
UZ - Uzbekistan 1
YE - Yemen 1
YT - Mayotte 1
Totale 6.112
Città #
Ashburn 366
San Jose 285
Singapore 228
Fairfield 226
Hong Kong 205
Dallas 180
Santa Clara 174
Woodbridge 150
Chandler 149
Houston 124
Seattle 107
New York 89
Shanghai 88
Beijing 82
Ann Arbor 80
Sofia 78
Council Bluffs 77
Wilmington 77
Cambridge 70
Los Angeles 70
Boardman 62
Munich 60
Milan 59
Serra 49
Ho Chi Minh City 46
Princeton 41
Abidjan 39
Florence 35
Frankfurt am Main 35
Vienna 34
Lauterbourg 31
Rome 31
Lawrence 29
Hanoi 28
Medford 26
Turku 26
Pisa 25
Hefei 23
London 19
Tokyo 19
Buffalo 17
São Paulo 16
Warsaw 16
Des Moines 15
Paris 15
Boulder 14
Ottawa 14
San Diego 14
Seoul 14
Bremen 13
Dong Ket 13
Redwood City 13
Redondo Beach 12
Dakar 11
Brno 10
Dearborn 10
Istanbul 10
Brooklyn 9
Nanjing 9
Phoenix 9
Belo Horizonte 8
Fuzhou 8
Hebei 8
Helsinki 8
Montreal 8
Norwalk 8
Washington 8
Caracas 7
Chicago 7
Columbus 7
Dhaka 7
Jacksonville 7
Toronto 7
Amsterdam 6
Baltimore 6
College Station 6
Genoa 6
Lahore 6
Lucca 6
Ogden 6
Pune 6
Quanzhou 6
Rio de Janeiro 6
Shenyang 6
The Dalles 6
Atlanta 5
Brussels 5
Chennai 5
Dulles 5
Düsseldorf 5
Guayaquil 5
Kaohsiung City 5
La Spezia 5
Lappeenranta 5
Manchester 5
Orem 5
Poplar 5
San Francisco 5
Shenzhen 5
Zhengzhou 5
Totale 4.121
Nome #
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 276
Occurrence of seizures and EEG interictal epileptiform discharges in AD patients and their correlation with clinical features: a cross-sectional study 242
The precuneus-a witness for excessive aβ gathering in alzheimer's disease pathology 227
Sexual headache: two familiar orgasmic headache cases and review of the literature. 219
Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer's disease: a multimodal neuroimaging study 214
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 210
Association Between CSF Beta-Amyloid and Apathy in Early-Stage Alzheimer Disease 204
A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. 190
Oxidative stress assessment in Alzheimer's disease: a clinic setting study 184
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers 183
Migraine features in migraineurs with and without anxiety-depression symptoms: A hospital-based study 179
Biological determinants of blood-based cytokines in the Alzheimer's Disease clinical continuum 177
Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology 171
Affective theory of mind in patients with Parkinson's disease 163
Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia 157
Biomarker-guided clustering of Alzheimer's disease clinical syndromes 157
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints 156
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development 154
Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD 148
A frontline defense against neurodegenerative diseases:the development of early disease detection methods 147
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease 147
α-synuclein as an emerging pathophysiological biomarker of Alzheimer's disease 147
Precision pharmacology for Alzheimer's disease 144
Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease 140
Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases 139
Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence 136
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease 132
Future avenues for Alzheimer's disease detection and therapy: Liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery 132
Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer’s and other neurodegenerative diseases 129
Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies 123
Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers 119
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases 113
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers 109
Plasma tau correlates with basal forebrain atrophy rates in people at risk for alzheimer disease 108
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers 103
Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints 99
Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases 90
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease 76
Alzheimer's disease pathophysiology in the Retina 73
Locus coeruleus magnetic resonance imaging correlates with [18F]Fluoro deoxyglucose uptake in Alzheimer's disease patients 72
Structural white matter connectivity differences independent of gray matter loss in mild cognitive impairment with neuropsychiatric symptoms: Early indicators of Alzheimer's disease using network-based statistics 50
Lithium as a Treatment for Alzheimer’s Disease: The Systems Pharmacology Perspective 26
Biomarker-drug and liquid biopsy co-development for disease staging and targeted therapy: Cornerstones for Alzheimer’s precision medicine and pharmacology 26
Commentary: Development of the Blood-Based Alzheimer's Disease Liquid Biopsy 18
Basal forebrain volume, but not hippocampal volume, is a predictor of global cognitive decline in patients with alzheimer's disease treated with cholinesterase inhibitors 16
Totale 6.225
Categoria #
all - tutte 19.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022357 0 0 12 23 81 40 7 18 16 13 41 106
2022/2023571 68 92 47 40 47 59 3 39 116 3 44 13
2023/2024421 30 43 48 36 38 78 34 14 4 11 30 55
2024/20251.280 14 41 39 90 117 126 104 55 126 153 165 250
2025/20261.934 144 218 227 218 179 120 266 81 100 242 79 60
2026/2027277 47 146 84 0 0 0 0 0 0 0 0 0
Totale 6.225